The US Food and Drug Administration (FDA) has approved Merck's Noxafil (posaconazole) 100 mg delayed-release tablets. The tablets are a new formulation with a loading dose of 300mg (three 100mg delayed-release tablets) twice daily on the ...
Agalimmune, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours. The new company has been founded by an investment group comprising Loxbridge ...
Tags: solid tumours, cancer treatment
U.S. scientists report progress of a hormone therapy that can improve the outcome of bone grafts to treat bone loss from disease, birth defects or trauma. Zulma Gazit at Cedars-Sinai Medical Center, Edward Schwarz of Rochester University ...
Tags: parathyroid, hormone, outcome, bone, graft
Medtronic's Valiant 'Mona LSA' branch thoracic stent graft system demonstrated proof of concept in a first-in-human study being conducted under the US Food and Drug Administration (FDA)'s ‘Innovation Pathway’ early feasibility ...
Tags: stent graft system, Medicine
Merck has secured priority review status from the US Food and Drug Administration (FDA) for its new drug application (NDA) for an investigational intravenous (IV) solution formulation of its antifungal agent, Noxafil (posaconazole), ...
ChoiceSpine, a medical device company, has introduced its Typhoon facet screw fixation system, designed to perform facet arthrodesis and posterior stabilization of the lumbar spine. ChoiceSpine's Typhoon facet screw fixation system is ...
Tags: ChoiceSpine, Typhoon Facet
W. L. Gore & Associates (Gore) has obtained CE Mark approval for its GORE EXCLUDER iliac branch endoprosthesis, designed for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms. Gore has designed the iliac ...
Tags: CE, Gore, GORE EXCLUDER, product line
W. L. Gore & Associates (Gore) has obtained an approval from the US Food and Drug Administration (FDA) for its 25cm GORE VIABAHN endoprosthesis with heparin bioactive surface. The 25cm Gore Viabahn endoprosthesis is intended to treat ...
Tags: disease heal, health, cure, fda
One Lambda, a part of Thermo Fisher Scientific, has obtained CE Mark approval for its C1qScreen assay in Europe. Utilizing Luminex-based single antigen beads, the C1qScreen solid-phase assay allows clinicians to further characterize ...
Tags: One Lambda, C1qscreen Assay
If the community edition of the JBoss enterprise Java application server could no longer be called JBoss,what other name would you choose?JOpen?JWorker?JFree?JMinion?JBoss community users get to decide. Red Hat is planning to change the ...
Tags: Red Hat, Linux, middleware, JBoss
RTI Surgical, a surgical implant company, has announced the first US implantation of its map3 cellular allogeneic bone graft in a foot and ankle procedure. Map3 cellular allogeneic bone graft is based on Athersys' licensed multipotent ...
BASF announced that it has appointed Archway Sales Inc., as a distributor for polyurethane chemicals to the Coatings, Adhesives & Binders, Sealants and Elastomers (CASE) market in the Ohio Valley. Effective January 1, 2014, Archway will be ...
Tags: Basf, Construction, chemicals
Medical technology company Lombard Medical Technologies successfully treated the first US patients with Aorfix, its flexible stent graft for the endovascular repair of abdominal aortic aneurysms (AAAs). Meriter Hospital vascular surgeon ...
Tags: Aortic Stent Graft
CryoLife has announced the first European clinical implant of its HeRO (Haemodialysis Reliable Outflow) graft following its CE Mark in June 2013. The procedure was performed at the University of Leuven Hospital in Belgium by Professor ...
Tags: CryoLife, Outflow Graft
US-based Cook Medical has introduced Biodesign ENT Repair Graft, which acts as an adjunct to help in the healing process following nasal and sinus mucosal surgery. The latest Biodesign offering from Cook Medical's Otolaryngology-Head and ...
Tags: Cook Medical, Medicine